Tech Company Financing Transactions
Antidote Health Funding Round
Antidote Health, operating out of New York, secured $22 million from Flint Capital, Group 11 and iAngels.
Transaction Overview
Company Name
Announced On
3/24/2022
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series A
Investors
Flint Capital (Lead Investor)
Group 11 (Lead Investor) (Dovi Frances)
iAngels (Lead Investor) (Shelly Moyal)
Proceeds Purpose
The telehealth company will use the investment to accelerate its growth in the United States, providing affordable, high-quality healthcare to more Americans nationwide.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
1460 Broadway St.
New York, NY 10036
USA
New York, NY 10036
USA
Phone
Website
Email Address
Overview
Antidote Health is a B2C company providing uninsured and underinsured Americans with a virtual HMO via Artificial Intelligence that connects users to doctors with a smart chatbot and through video calls.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Avihai Soudri
Browse more venture capital transactions:
Prev: 3/24/2022: Reach Digital venture capital transaction
Next: 3/24/2022: Digits venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs